Description

3H-Cyclopenta[C]Pyridin-3-One,Octahydro-7-Methyl-,(4Ar,7S,7Ar)-(9Ci) is a high-purity, advanced pharmaceutical intermediate with a complex, stereochemically defined bicyclic structure. This compound matters as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), enabling the development of targeted therapeutics. It is primarily needed by research institutions and pharmaceutical companies engaged in medicinal chemistry, process development, and the production of complex small-molecule drugs.

Application

• Pharmaceutical Intermediate: A key chiral synthon in the research and development of new drug candidates, particularly for central nervous system (CNS) or anti-infective applications.
• Medicinal Chemistry Research: Serves as a versatile scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Process Chemistry: Used in the scale-up and optimization of synthetic routes for complex organic molecules under Good Manufacturing Practice (GMP) conditions.
• Asymmetric Synthesis: Exploits its defined stereochemistry (4Ar,7S,7Ar) for the construction of other enantiomerically pure compounds.
• Reference Standard: Can be supplied as a high-purity analytical standard for quality control and method validation in analytical laboratories.

Basic Information

Product Name	3H-Cyclopenta[C]Pyridin-3-One,Octahydro-7-Methyl-,(4Ar,7S,7Ar)-(9Ci)
CAS No.	479041-73-1
Molecular Formula	C9H15NO
Molecular Weight	153.22 g/mol
Synonyms	Octahydro-7-methyl-3H-cyclopenta[c]pyridin-3-one; (4aR,7S,7aR)-Octahydro-7-methyl-3H-cyclopenta[c]pyridin-3-one; 7-Methyloctahydro-3H-cyclopenta[c]pyridin-3-one; 479041-73-1; (4aR,7S,7aR)-7-Methyloctahydrocyclopenta[c]pyridin-3(1H)-one; Stereoisomer of octahydro-7-methyl-3H-cyclopenta[c]pyridin-3-one
EINECS	Contact for details

Quality Control

Our 3H-Cyclopenta[C]Pyridin-3-One,Octahydro-7-Methyl-,(4Ar,7S,7Ar)-(9Ci) is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including chiral purity verification, to ensure it meets the stringent requirements for pharmaceutical R&D and cGMP applications. A comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). For long-term storage, consider inert atmosphere conditions to maintain optimal stability.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Assay (HPLC)	≥ 98.0%
Chiral Purity (Chiral HPLC)	≥ 99.0% ee
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 1.0%
Residual Solvents (GC)	Meets ICH Q3C guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.